Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
Post
-
-
FDA approves GSK’s Wellcovorin for cerebral folate deficiency
The US Food and Drug Administration (FDA) has granted its approval for the expanded use of GSK’s Wellcovorin (leucovorin calcium) …
-
QT Imaging secures FDA clearance for updated Breast Acoustic CT scanner
QT Imaging has received the US Food and Drug Administration (FDA) 510(k) clearance for an updated configuration of its Breast …
-
Kainova reports positive top line results from Phase I EPRAD trial
Canada-based Kainova Therapeutics has reported positive top line results from the Phase I EPRAD study of DT-9081, an oral EP4 …
-
Building for decades: Dubai’s long game in life sciences
Editor's note: This feature was reported in part prior to the escalation of hostilities in the Gulf, when Iran launched …
-
GE HealthCare secures FDA 510(k) clearance for diagnostic viewer
GE HealthCare has received 510(k) clearance from the US Food and Drug Administration (FDA) for View, the diagnostic viewer within …
-
Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
-
AbbVie reports topline data from Phase I ABBV-295 trial
AbbVie has reported positive top line data from the multiple ascending dose (MAD) section of its Phase I trial of …
-
NewcelX and Eledon partner for NCEL-101 programme
NewcelX has signed a collaborative research agreement with Eledon Pharmaceuticals to advance its NCEL-101 programme for type 1 diabetes (T1D). The …
-
LifeVac receives FDA De Novo classification for anti-choking device
LifeVac has received De Novo classification from the US Food and Drug Administration (FDA) for its suction anti-choking device under …
-
Aisa Pharma reports positive results for AISA-021
Aisa Pharma has reported positive results from its Phase II RECONNOITER trial of AISA-021 (cilnidipine), a once-daily calcium channel blocker, …
-
BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment
Bristol Myers Squibb (BMS) has received the US Food and Drug Administration (FDA) approval for Sotyktu (deucravacitinib), an oral selective …
-
Cognita secures FDA breakthrough device designation for CXR
Cognita has received the US Food and Drug Administration (FDA) breakthrough device designation for the Chest X-Ray (CXR) model across …
-
Seqster unveils 1-Click DataLake for clinical trials
Seqster has launched 1-Click DataLake, a real-world data platform to expedite trial design, recruitment, and evidence generation for healthcare and …
-
Liberate Bio gains licences for myeloid-specific CAR design patents
Liberate Bio has obtained both exclusive and non-exclusive licences for patents related to chimeric antigen receptor (CAR) designs tailored for …
-
Philips launches Rembra CT system for acute imaging
Philips has unveiled its next-generation radiology computed tomography (CT) system, Rembra, to address the challenges faced by acute and high-demand …
-
HUTCHMED begins Phase I/IIa trial of HMPL-A580 for solid tumours
HUTCHMED has commenced a Phase I/IIa clinical trial of its second antibody-targeted therapy conjugate (ATTC), HMPL-A580, targeting patients with unresectable, …
